ATE393633T1 - Verbindungen die ein an einen vektor gebundenes analgetisches molekül enthalten - Google Patents

Verbindungen die ein an einen vektor gebundenes analgetisches molekül enthalten

Info

Publication number
ATE393633T1
ATE393633T1 AT02704883T AT02704883T ATE393633T1 AT E393633 T1 ATE393633 T1 AT E393633T1 AT 02704883 T AT02704883 T AT 02704883T AT 02704883 T AT02704883 T AT 02704883T AT E393633 T1 ATE393633 T1 AT E393633T1
Authority
AT
Austria
Prior art keywords
vector
compounds containing
analgesic molecule
molecule bonded
analgesic
Prior art date
Application number
AT02704883T
Other languages
English (en)
Inventor
Jamal Temsamani
Anthony Rees
Philippe Clair
Original Assignee
Synt Em
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synt Em filed Critical Synt Em
Application granted granted Critical
Publication of ATE393633T1 publication Critical patent/ATE393633T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Image Analysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT02704883T 2001-02-23 2002-02-22 Verbindungen die ein an einen vektor gebundenes analgetisches molekül enthalten ATE393633T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0102504A FR2821272B1 (fr) 2001-02-23 2001-02-23 Composes constitues d'une molecule analgesique liee a un vecteur capable de vectoriser ladite molecule a travers la barriere hematoencephalique et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
ATE393633T1 true ATE393633T1 (de) 2008-05-15

Family

ID=8860381

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02704883T ATE393633T1 (de) 2001-02-23 2002-02-22 Verbindungen die ein an einen vektor gebundenes analgetisches molekül enthalten

Country Status (11)

Country Link
US (1) US20040248806A1 (de)
EP (1) EP1397161B1 (de)
JP (1) JP2004529886A (de)
AT (1) ATE393633T1 (de)
AU (1) AU2002238687B2 (de)
CA (1) CA2438824A1 (de)
DE (1) DE60226319T2 (de)
ES (1) ES2305204T3 (de)
FR (1) FR2821272B1 (de)
IL (1) IL157214A0 (de)
WO (1) WO2002067994A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2864082B1 (fr) * 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur
FR2907121B1 (fr) * 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques
UY32099A (es) 2008-09-11 2010-04-30 Enanta Pharm Inc Inhibidores macrocíclicos de serina proteasas de hepatitis c
FR2968662B1 (fr) 2010-12-10 2013-11-22 Roussy Inst Gustave Nouveaux derives d'oxazaphosphorines pre-activees, utilisation et methode de preparation
CA2822556A1 (en) 2010-12-30 2012-07-05 Enanta Pharmaceuticals, Inc Macrocyclic hepatitis c serine protease inhibitors
EA201390988A1 (ru) 2010-12-30 2014-04-30 Энанта Фармасьютикалз, Инк. Фенантридиновые макроциклические ингибиторы сериновой протеазы вируса гепатита c
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
CN103012596B (zh) * 2012-12-28 2014-12-03 兰州大学 具有血脑屏障通透性的内吗啡肽衍生肽及其合成和应用
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767323B1 (fr) * 1997-08-12 2001-01-05 Synt Em Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
US6258774B1 (en) * 1998-03-19 2001-07-10 University Of Medicine And Dentistry Of New Jersey Carrier for in vivo delivery of a therapeutic agent
FR2786397B1 (fr) * 1998-11-30 2003-01-10 Synt Em Vecteurs peptidiques de substances a travers la barriere hematoencephalique pour etre utilises dans le diagnostic ou la therapie d'une affection du snc
FR2786398B1 (fr) * 1998-11-30 2002-12-27 Synt Em Composition pharmaceutique anti-cancereuse et anti-chimioresistance comprenant un agent anticancereux et au moins un peptide

Also Published As

Publication number Publication date
DE60226319T2 (de) 2009-07-09
ES2305204T3 (es) 2008-11-01
EP1397161B1 (de) 2008-04-30
FR2821272A1 (fr) 2002-08-30
EP1397161A2 (de) 2004-03-17
IL157214A0 (en) 2004-02-19
DE60226319D1 (de) 2008-06-12
US20040248806A1 (en) 2004-12-09
FR2821272B1 (fr) 2004-12-17
AU2002238687B2 (en) 2006-10-05
CA2438824A1 (fr) 2002-09-06
WO2002067994A2 (fr) 2002-09-06
WO2002067994A3 (fr) 2003-12-24
JP2004529886A (ja) 2004-09-30

Similar Documents

Publication Publication Date Title
SE0104140D0 (sv) Novel Compounds
SE0200920D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
IS2376B (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
ATE433447T1 (de) Pyrimiidinverbindungen
NO20026064D0 (no) Nye forbindelser
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
SE0300480D0 (sv) Novel compounds
SE0202133D0 (sv) Novel compounds
DE60034240D1 (de) Drogen zur behandlung maligner tumoren
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
EA200401526A1 (ru) Новые соединения и их применение
MXPA05012837A (es) Inhibidores de caspasa y usos de los mismos.
DE60112330D1 (en) Pyrazolopyridinderivate
SE0302139D0 (sv) Novel compounds
NO20060446L (no) Trisykliske delta-opioidmodulatorer
TW200604197A (en) New compounds
DE60228484D1 (de) Cytotoxische mittel
ATE393633T1 (de) Verbindungen die ein an einen vektor gebundenes analgetisches molekül enthalten
SE0101038D0 (sv) Novel compounds
SE0303280D0 (sv) Novel compounds
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties